Talks on the Trans-Pacific Partnership, which would cut trade barriers and set common standards across 40 percent of the world economy, have been extended into a fifth day in a bid to resolve an impasse over monopoly periods for medicines.
Groser said failure to seal the deal - already more than five years in the making - would be a bad sign for attempts to bind countries together through trade and investment links.World Trade Organization efforts were blocked and Europe was cooling on efforts to harmonize rules through a trade and investment deal with the United States."You can see the summit within reach and it's just a question as to whether or not you've got just enough political energy to reach out and do the last little bit," he told reporters.If the United States "cannot find a way with its negotiating partners to bring it to a conclusion here ... you've got to say that this is a massive psychological blow to the other arm of strategic U.S. policy."The TPP talks are stuck over rules dictating how quickly low-cost versions of biological drugs can come to market, with Australia and others resisting U.S. pressure to increase the standard past five years.The impasse is holding up a deal on dairy trade, which is crucial for New Zealand, home to the world's biggest dairy exporter Fonterra